1AD
Click for more information
0.00% 2.5¢ adalta limited

Ann: Positive AD-214 Phase I extension study results, page-189

  1. asx11
    3,512 Posts.
    lightbulb Created with Sketch. 377
    clock Created with Sketch.
    27/03/24
    10:39
    Post #: 73078395
    They wouldn't get the company for that because we wouldn't allow it. The company also has 2 paths to funding, they may not even end up partnering with pharma.
    Last edited by asx11: 27/03/24
    1AD Price at posting: 2.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
SKS SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
right-arrow Created with Sketch.
I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $14.89M
Open High Low Value Volume
2.5¢ 2.5¢ 2.5¢ $11.70K 468.2K

Buyers (Bids)

No. Vol. Price($)
1 500000 2.4¢
 

Sellers (Offers)

Price($) Vol. No.
2.5¢ 107132 2
View Market Depth
Last trade - 15.42pm 12/07/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.